Text Size

Using High Resolution Function Imaging To Detect Melanoma and Dysplastic Nevi

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2010 by Sidney Kimmel Comprehensive Cancer Center.
Recruitment status was  Recruiting
Sponsor:
Collaborators:
Johns Hopkins University
Boston University
Information provided by:
Sidney Kimmel Comprehensive Cancer Center
ClinicalTrials.gov Identifier:
NCT01118832
First received: May 5, 2010
Last updated: May 6, 2010
Last verified: May 2010
History of Changes
  Purpose

A novel infrared imaging tool to aid in the clinical detection of atypical pigmented lesions and melanoma is developed. Goals include evaluation of the utility of high-resolution infrared scanning of cutaneous lesions in the diagnosis of pigmented lesions and the identification of high-risk lesions and melanomas.


Condition
Melanoma

Study Type: Observational
Study Design: Observational Model: Case-Only
Official Title: Using High Resolution Function Imaging To Detect Melanoma and Dysplastic Nevi

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Sidney Kimmel Comprehensive Cancer Center:

Estimated Enrollment: 30
Study Start Date: September 2009
  Eligibility

Ages Eligible for Study:   10 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

The subject population will be identified in the Department of Dermatology Pigmented Lesion Clinic at the Johns Hopkins Hospital Outpatient Center. Recruited patients will only comprise those requesting a cutaneous pigmented lesion removed or patients that are examined and found to have a pigmented lesion that is suspicious for malignancy at the time of their visit, and thus recommended to have a skin biopsy for diagnosis following the standard of care

Criteria

Inclusion Criteria:

  • Patients seen in the high-risk pigmented lesion clinic, who posses a pigmented lesion with a clinical indication for biopsy

Exclusion Criteria:

  • None
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01118832

Locations
United States, Maryland
Johns Hopkins Medicine Recruiting
Baltimore, Maryland, United States, 21287
Contact: Rhoda Alani, MD     617-638-5517     ralani@jhmi.edu    
Sponsors and Collaborators
Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins University
Boston University
Investigators
Principal Investigator: Rhoda Alani, MD Johns Hopkins University
  More Information

No publications provided

Responsible Party: Rhoda Alani, Johns Hopkins University
ClinicalTrials.gov Identifier: NCT01118832     History of Changes
Other Study ID Numbers: J0868, NA_00016040
Study First Received: May 5, 2010
Last Updated: May 6, 2010
Health Authority: United States: Institutional Review Board

Keywords provided by Sidney Kimmel Comprehensive Cancer Center:
Thermography

Additional relevant MeSH terms:
Melanoma
Dysplastic Nevus Syndrome
Neuroendocrine Tumors
Neuroectodermal Tumors
Neoplasms, Germ Cell and Embryonal
Neoplasms by Histologic Type
 Neoplasms
Neoplasms, Nerve Tissue
Nevi and Melanomas
Nevus
Neoplastic Syndromes, Hereditary
Genetic Diseases, Inborn

ClinicalTrials.gov processed this record on June 18, 2013